Diffuse Large B Cell Lymphoma (DLBCL): Clinical Trials

2 trials for Diffuse Large B Cell Lymphoma (DLBCL), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Recruiting 2

Follow Diffuse Large B Cell Lymphoma (DLBCL): new trials by email Literature Review of Diffuse Large B Cell Lymphoma (DLBCL) trials Research Report on Diffuse Large B Cell Lymphoma (DLBCL)

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Proton Therapy for Mediastinal Lymphoma (PROMLY)
Proton therapy - Mediastinal Lymphoma, Hodgkin Disease Lymphoma
Not applicableRecruitingCopenhagen University Hospital, Rigshospitalet1392026-05-012026-09-14
Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors
Lifestyles Implemented-Survivorship Care Plan (LS-SCP) - Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL)
Not applicableRecruitingFondazione Italiana Linfomi - ETS5522024-02-262026-09-11

Narrower conditions

Lymphoma, Large B-Cell, Diffuse (2)  ·  Hodgkin Disease (1)  ·  Lymphoma (1)  ·  Motor Activity (1)

Broader conditions

Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma, B-Cell (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Behavior (1)  ·  Lymphoma (1)

Interventions

Proton Therapy (1)

Sponsors

Copenhagen University Hospital, Rigshospitalet (1)  ·  Fondazione Italiana Linfomi - ETS (1)

Countries

Denmark (1)  ·  Italy (1)

Top investigators

Carla Minoia, MD (1)